211 related articles for article (PubMed ID: 33515675)
1. SHCBP1 interacting with EOGT enhances O-GlcNAcylation of NOTCH1 and promotes the development of pancreatic cancer.
Yang C; Hu JF; Zhan Q; Wang ZW; Li G; Pan JJ; Huang L; Liao CY; Huang Y; Tian YF; Shen BY; Chen JZ; Wang YD; Chen S
Genomics; 2021 Mar; 113(2):827-842. PubMed ID: 33515675
[TBL] [Abstract][Full Text] [Related]
2. Impaired O-linked N-acetylglucosaminylation in the endoplasmic reticulum by mutated epidermal growth factor (EGF) domain-specific O-linked N-acetylglucosamine transferase found in Adams-Oliver syndrome.
Ogawa M; Sawaguchi S; Kawai T; Nadano D; Matsuda T; Yagi H; Kato K; Furukawa K; Okajima T
J Biol Chem; 2015 Jan; 290(4):2137-49. PubMed ID: 25488668
[TBL] [Abstract][Full Text] [Related]
3.
Alam SMD; Tsukamoto Y; Ogawa M; Senoo Y; Ikeda K; Tashima Y; Takeuchi H; Okajima T
J Biol Chem; 2020 Jun; 295(25):8560-8574. PubMed ID: 32376684
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAc on NOTCH1 EGF repeats regulates ligand-induced Notch signaling and vascular development in mammals.
Sawaguchi S; Varshney S; Ogawa M; Sakaidani Y; Yagi H; Takeshita K; Murohara T; Kato K; Sundaram S; Stanley P; Okajima T
Elife; 2017 Apr; 6():. PubMed ID: 28395734
[TBL] [Abstract][Full Text] [Related]
5. O-linked-N-acetylglucosamine modification of mammalian Notch receptors by an atypical O-GlcNAc transferase Eogt1.
Sakaidani Y; Ichiyanagi N; Saito C; Nomura T; Ito M; Nishio Y; Nadano D; Matsuda T; Furukawa K; Okajima T
Biochem Biophys Res Commun; 2012 Mar; 419(1):14-9. PubMed ID: 22310717
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics and Functional Analyses Implicate Potential Roles for EOGT and L-fringe in Pancreatic Cancers.
Barua R; Mizuno K; Tashima Y; Ogawa M; Takeuchi H; Taguchi A; Okajima T
Molecules; 2021 Feb; 26(4):. PubMed ID: 33562410
[TBL] [Abstract][Full Text] [Related]
7. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
[TBL] [Abstract][Full Text] [Related]
8. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia induces TWIST-activated epithelial-mesenchymal transition and proliferation of pancreatic cancer cells in vitro and in nude mice.
Chen S; Chen JZ; Zhang JQ; Chen HX; Yan ML; Huang L; Tian YF; Chen YL; Wang YD
Cancer Lett; 2016 Dec; 383(1):73-84. PubMed ID: 27693633
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAcylation promotes pancreatic tumor growth by regulating malate dehydrogenase 1.
Zhu Q; Zhou H; Wu L; Lai Z; Geng D; Yang W; Zhang J; Fan Z; Qin W; Wang Y; Zhou R; Yi W
Nat Chem Biol; 2022 Oct; 18(10):1087-1095. PubMed ID: 35879546
[TBL] [Abstract][Full Text] [Related]
11. Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma.
Peng C; Zhao H; Chen W; Song Y; Wang X; Li J; Qiao Y; Wu D; Ma S; Wang X; Gao C
Oncotarget; 2016 Oct; 7(41):66822-66834. PubMed ID: 27572315
[TBL] [Abstract][Full Text] [Related]
12. Regulation of pancreatic cancer TRAIL resistance by protein O-GlcNAcylation.
Yang SZ; Xu F; Yuan K; Sun Y; Zhou T; Zhao X; McDonald JM; Chen Y
Lab Invest; 2020 May; 100(5):777-785. PubMed ID: 31896813
[TBL] [Abstract][Full Text] [Related]
13. SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis.
Xu N; Wu YP; Yin HB; Chen SH; Li XD; Xue XY; Gou X
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1953-1969. PubMed ID: 32447485
[TBL] [Abstract][Full Text] [Related]
14. Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma.
Chen Y; Li Z; Zhang M; Wang B; Ye J; Zhang Y; Tang D; Ma D; Jin W; Li X; Wang S
J Exp Clin Cancer Res; 2019 Nov; 38(1):466. PubMed ID: 31718694
[TBL] [Abstract][Full Text] [Related]
15. Cellular Prion Protein Mediates Pancreatic Cancer Cell Survival and Invasion through Association with and Enhanced Signaling of Notch1.
Wang Y; Yu S; Huang D; Cui M; Hu H; Zhang L; Wang W; Parameswaran N; Jackson M; Osborne B; Bedogni B; Li C; Sy MS; Xin W; Zhou L
Am J Pathol; 2016 Nov; 186(11):2945-2956. PubMed ID: 27639164
[TBL] [Abstract][Full Text] [Related]
16. SHCBP1 promotes cisplatin induced apoptosis resistance, migration and invasion through activating Wnt pathway.
Zou A; Wu A; Luo M; Zhou C; Lu Y; Yu X
Life Sci; 2019 Oct; 235():116798. PubMed ID: 31472149
[TBL] [Abstract][Full Text] [Related]
17. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.
Ma Z; Vocadlo DJ; Vosseller K
J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772
[TBL] [Abstract][Full Text] [Related]
18. The EGF repeat-specific O-GlcNAc-transferase Eogt interacts with notch signaling and pyrimidine metabolism pathways in Drosophila.
Müller R; Jenny A; Stanley P
PLoS One; 2013; 8(5):e62835. PubMed ID: 23671640
[TBL] [Abstract][Full Text] [Related]
19. EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation.
Yin H; Zhang C; Wei Z; He W; Xu N; Xu Y; Li T; Ren K; Kuang Y; Zhu X; Yuan F; Yu H; Gou X
Cell Death Dis; 2022 Jan; 13(1):39. PubMed ID: 35013128
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAcylation and stablization of SIRT7 promote pancreatic cancer progression by blocking the SIRT7-REGγ interaction.
He X; Li Y; Chen Q; Zheng L; Lou J; Lin C; Gong J; Zhu Y; Wu Y
Cell Death Differ; 2022 Oct; 29(10):1970-1981. PubMed ID: 35422493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
